期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

异基因造血干细胞移植治疗骨髓增生异常综合征的时机选择 被引量：1

原文传递
导出
摘要 骨髓增生异常综合征(myelodysplastic syndrome,MDS)是造血干细胞性克隆性疾病,主要表现为贫血、出血和严重感染,并具有向急性白血病转化的危险性。在过去的数十年中,虽然很多新药应用于临床,然而迄今为止,异基因造血干细胞移植仍然是治愈MDS的唯一手段,而干细胞移植的时机是人们争论的焦点。作者从发病到移植的时间、疾病缓解情况及去甲基化治疗药物在异基因造血干细胞移植治疗MDS中的应用三个方面作一综述。
作者 周婷婷 丁家华
机构地区 东南大学医学院附属中大医院血液科
出处 《现代医学》 2013年第4期279-281,共3页 Modern Medical Journal
关键词 异基因造血干细胞移植 骨髓增生异常综合征 时机 文献综述
分类号 R551.3 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献17

  • 1VARDIMAN J W,HARRIS N L,BRUNNING R D. The WorldHealth Organization (WHO) classification of the myeloid neo-plasms [J]. Blood,2002,100(7) :2292-2302.
  • 2肖志坚.骨髓增生异常综合征:现况与问题[J].白血病．淋巴瘤,2005,14(4):193-196. 被引量：30
  • 3DEEG H J,STORER B, SLATTERY J T,et al. Conditioningwith targeted busulfan and cyclophosphamide for hemopoieticstem cell transplantation from related and unrelated donors inpatients with myelodysplastic syndrome[ J] . Blood,2002,100(4):1201-1207.
  • 4CUTLER C S,LEE S J,GREENBERG P,et al. A decision a-nalysis of allogeneic bone marrow transplantation for the myel-odysplastic syndromes : delayed transplantation for low-risk my-elodysplasia is associated with improved outcome[ J]. Blood,104(2) :579-585.
  • 5BERNASCONI C. Evidence- based approach to treatment ofmyelody splastic syndromes[ J]. Haematologica,2001,86(9):897-899.
  • 6刘代红,黄晓军.骨髓增生异常综合征的异基因造血干细胞移植[J].中国实用内科杂志,2010,30(5):392-394. 被引量：3
  • 7de WITTE T,BRAND R, van BIEZEN A,et al. Allogeneicstem cell transplantation for patients with refractory anaemiawith matched related and unrelated donors : delay of the trans-plant is associated with inferior survival [ J ]. Br J Haematol,2009,146:627-636.
  • 8DEMUYNGK H,VERHOEF G E,ZACHEE P,et al. Treatmentof patients with myelodysplastic syndromes with allogeneicbone marrow transplantation from genotypically HLA-identicalsibling and alternative donors [ J]. Bone Marrow Transplant,1996,17(5) :745-751.
  • 9de WITTE T, HERMANS J, VOSSEN J, et al. Haematopoieticstem cell transplantation for patients with myelo- dysplastic sy-ndromes and secondary acute myeloid leukaemias: a report onbehalf of the Chronic Leukaemia Working Party of the Europe-an Group for Blood and Marrow Transplantation(EBMT) [ J].Br J Haematol,2000,110(3) :620-630.
  • 10RUNDE V,de WITTE T,ARNOLD R,et al. Bone marrowtransplantation from HLA-identical siblings as first-line treat-ment in patients with my elodysplastic syndromes : early trans-plantation is associated with improved outcome. Chronic Leu-kemia Working Party of the European Group for Blood andMarrow Transplantation[ J]. Bone Marrow Transplant, 1998,21(3) :255-261.

二级参考文献11

  • 1Cutler CS, Lee S J, Greenberg P, et al. A decision analysis of allogeneic bone marrow transplantation foe the myelodysplastic syndromes : delayed transplantation for low risk myelodysplasia is associated with improved outcome[ J]. Blood,2004,104:579 - 585.
  • 2Deeg H J, Storer B, Slattery JT, et al. Conditioning with targeted busulfan and cyclophosphomide for hematopoietic stem cell transplantation fromrelated and unrelated donors in patients with myelodysplastic syndrome[ J]. Blood ,2002,100:1201 - 1207.
  • 3Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML) : results of the EWOG-MDS/EBMT trial [ J]. Blood ,2005,105:410 - 419.
  • 4Guardiola P, Runde V, Bacigalupo A et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating faCtor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes [ J ]. Blood, 2002,99:4370 - 4378.
  • 5de Witte T, Oosterveld M, Muus P. Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome [ J ]. Blood Rev, 2007,21 :49 -59.
  • 6Lu DP, Dong LJ, Wu T, et al. Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation[J]. Blood ,2006,107:3065 - 3073.
  • 7Chen Y,Liu K, Xu L, et al. HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome [ J/ OL]. Bone Marrow Transplant,2010.
  • 8Rodrigo M, Simona I, Ronald B, et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes [ J ]. Blood ,2006,108:836 - 846.
  • 9Kindwall-Keller T, Isola LM. The evolution of hematopoietie SCT in myelodysplastic syndrome [ J ], Bone Marrow Transplant, 2009, 43(8) :597 -609.
  • 10Nakai K, Kanda Y, Fukuhara S. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome [ J ]. Leukemia ,2005,19:396 -401.

共引文献31

同被引文献5

引证文献1

二级引证文献3

现代医学
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部